Business Description
Epitomee Medical Ltd
ISIN : IL0011825911
Share Class Description:
XTAE:EPIT: Ordinary SharesDescription
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.79 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | -0.79 | |||||
| Interest Coverage | 7.28 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -20 | |||||
| 3-Year Book Growth Rate | 106 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.63 | |||||
| 9-Day RSI | 52.81 | |||||
| 14-Day RSI | 48.98 | |||||
| 6-1 Month Momentum % | -81.86 | |||||
| 12-1 Month Momentum % | -73.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.92 | |||||
| Quick Ratio | 17.92 | |||||
| Cash Ratio | 17.79 | |||||
| Days Sales Outstanding | 14.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -6.7 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | 4.16 | |||||
| Net Margin % | -56.82 | |||||
| FCF Margin % | -119.96 | |||||
| ROE % | -15.61 | |||||
| ROA % | -11.71 | |||||
| ROIC % | 4.52 | |||||
| ROC (Joel Greenblatt) % | -73.06 | |||||
| ROCE % | -12.07 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.45 | |||||
| PB Ratio | 0.7 | |||||
| Price-to-Tangible-Book | 0.7 | |||||
| EV-to-EBIT | 1.12 | |||||
| EV-to-EBITDA | 1.27 | |||||
| EV-to-Revenue | -0.63 | |||||
| EV-to-FCF | 0.51 | |||||
| Price-to-Net-Current-Asset-Value | 0.82 | |||||
| Price-to-Net-Cash | 0.83 | |||||
| Earnings Yield (Greenblatt) % | 89.04 | |||||
| FCF Yield % | -48.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Epitomee Medical Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 37.277 | ||
| EPS (TTM) (₪) | -0.716 | ||
| Beta | 0 | ||
| Volatility % | 115.12 | ||
| 14-Day RSI | 48.98 | ||
| 14-Day ATR (₪) | 0.094502 | ||
| 20-Day SMA (₪) | 3.00995 | ||
| 12-1 Month Momentum % | -73.53 | ||
| 52-Week Range (₪) | 2.9 - 19.48 | ||
| Shares Outstanding (Mil) | 29.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Epitomee Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Epitomee Medical Ltd Stock Events
| Event | Date | Price(₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
Epitomee Medical Ltd Frequently Asked Questions
What is Epitomee Medical Ltd(XTAE:EPIT)'s stock price today?
The current price of XTAE:EPIT is ₪3.08. The 52 week high of XTAE:EPIT is ₪19.48 and 52 week low is ₪2.90.
When is next earnings date of Epitomee Medical Ltd(XTAE:EPIT)?
The next earnings date of Epitomee Medical Ltd(XTAE:EPIT) is .
Does Epitomee Medical Ltd(XTAE:EPIT) pay dividends? If so, how much?
Epitomee Medical Ltd(XTAE:EPIT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers